ArticleSurgical endoscopy2025
Effect of sleeve gastrectomy on distal esophagus at 5 and 10 years.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gastroesophageal Reflux Disease 10 Years After Bariatric Surgery-Is It a Problem? A Multicenter Study (BARI-10-POL).Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSleeve gastrectomy (SG) is a primary surgical intervention for obesity management. However, several longitudinal studies have documented the emergence of long-term esophageal consequences, notably gastroesophageal reflux disease (GERD) and its associated complications. This study aimed to assess the occurrence of esophageal complications, including esophagitis and Barret's esophagus (BE), 5 and 10 years after SG, in one medical center.
methodsTwo cohorts of consecutive patients who underwent SG were studied: patients who underwent a systematic upper gastro-intestinal endoscopy (UGIE) at five years or conversion to RYGB < 5 years (cohort n°1, n = 219), and patients who underwent UGIE at 10 years or converted to RYGB > 5 years (cohort n°2, n = 72). Patients with missing UGIE before or after SG were excluded.
resultsIn the cohort n°1, 62.7% of the patients had clinical GERD at the 5-years follow-up (vs. 21.8 before SG, p < 0.0001), 27.4% had esophagitis (vs. 14.2% before SG, p = 0.0006), and 8.3% had BE (vs. 1.8% before SG, p = 0.002) with metaplasia in 1.8%. De novo esophagitis and BE accounted for 19.6% and 7.8%, respectively. In the cohort n°2, at 10 years, 61.5% had clinical GERD (vs.12.5 before SG, p < 0.0001), 23.6% had esophagitis (vs. 9.7% before SG, p = 0.025) including 20.8% de novo, and 8.3% had de novo BE, with metaplasia in 5.6%. De novo esophagitis accounted for 20.8%. One patient developed esophageal adenocarcinoma 10 years after SG. Pre-operative esophagitis was significantly associated with BE on UGIE at 5 or 10 years, while active smoking and preoperative esophagitis were risk factors for esophagitis.
conclusionThis study highlights a significant increase in esophageal complications 5 and 10 years after SG. Pre-operative esophagitis should be considered when choosing a surgical technique for obesity management.
Indexed as
Identifiers
39496945What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.